Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.30
    +1.40 (+1.71%)
     
  • GOLD FUTURES

    2,342.20
    -4.20 (-0.18%)
     
  • DOW

    38,511.63
    +271.65 (+0.71%)
     
  • Bitcoin GBP

    53,574.04
    +68.70 (+0.13%)
     
  • CMC Crypto 200

    1,436.95
    +22.19 (+1.57%)
     
  • NASDAQ Composite

    15,716.76
    +265.45 (+1.72%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript

Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript

Joining me on the call today are Ryan Spencer, chief executive officer; Kelly MacDonald, chief financial officer; Robert Janssen, chief medical officer; and Donn Casale, senior vice president, commercial. Before I begin, I advise you that we will be making forward-looking statements today, including statements regarding HEPLISAV-B's commercial profile, its potential to become the standard of care and for universal recommendation.